Impact of Type 2 Diabetes and Postmenopausal Hormone Therapy on Incidence of Cognitive Impairment in Older Women.
Espeland, Mark A
Impact of Type 2 Diabetes and Postmenopausal Hormone Therapy on Incidence of Cognitive Impairment in Older Women. [electronic resource] - Diabetes care Dec 2015 - 2316-24 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1935-5548
10.2337/dc15-1385 doi
Aged
Aged, 80 and over
Brain--drug effects
Cognition--drug effects
Cognition Disorders--chemically induced
Dementia--chemically induced
Diabetes Mellitus, Type 2--blood
Estrogen Replacement Therapy--adverse effects
Estrogens--blood
Estrogens, Conjugated (USP)--adverse effects
Female
Glucose--metabolism
Humans
Incidence
Medroxyprogesterone Acetate--adverse effects
Postmenopause
Randomized Controlled Trials as Topic
Risk
Impact of Type 2 Diabetes and Postmenopausal Hormone Therapy on Incidence of Cognitive Impairment in Older Women. [electronic resource] - Diabetes care Dec 2015 - 2316-24 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1935-5548
10.2337/dc15-1385 doi
Aged
Aged, 80 and over
Brain--drug effects
Cognition--drug effects
Cognition Disorders--chemically induced
Dementia--chemically induced
Diabetes Mellitus, Type 2--blood
Estrogen Replacement Therapy--adverse effects
Estrogens--blood
Estrogens, Conjugated (USP)--adverse effects
Female
Glucose--metabolism
Humans
Incidence
Medroxyprogesterone Acetate--adverse effects
Postmenopause
Randomized Controlled Trials as Topic
Risk